{"transactions":[{"id":965422,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":71334,"kind":"person","name":"Walker Karen Marie","position":1,"cik":"0002008556","reported_name":"Walker Karen Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-12-18T01:30:03.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":false,"shares":23998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the original number of shares subject to the option vested on January 1, 2025, and 1/48th of the original number of shares subject to the option vests in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":85865,"derivative":{"exercise_price":4.83,"expiration_date":"2033-11-05","underlying":"Common Stock","underlying_shares":23998},"source":{"system":"sec-edgar","filing":"0001193125-25-323332","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2008556/000119312525323332/ownership.xml","form_type":"4"}},{"id":965421,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":71334,"kind":"person","name":"Walker Karen Marie","position":1,"cik":"0002008556","reported_name":"Walker Karen Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-12-18T01:30:03.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":23998,"price":12.2,"value":292775.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions."}],"balance_after":22636,"source":{"system":"sec-edgar","filing":"0001193125-25-323332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2008556/000119312525323332/ownership.xml","form_type":"4"}},{"id":965420,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":71334,"kind":"person","name":"Walker Karen Marie","position":1,"cik":"0002008556","reported_name":"Walker Karen Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-12-18T01:30:03.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":true,"shares":23998,"price":4.83,"value":115910.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on September 12, 2025 in effect at the time of such transactions."}],"balance_after":46634,"source":{"system":"sec-edgar","filing":"0001193125-25-323332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008556/000119312525323332/ownership.xml","form_type":"4"}},{"id":1171934,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":71334,"kind":"person","name":"Walker Karen Marie","position":1,"cik":"0002008556","reported_name":"Walker Karen Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-15T21:40:15.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option shall vest on April 11, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":80000,"derivative":{"exercise_price":2.06,"expiration_date":"2035-04-11","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000950170-25-054342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2008556/000095017025054342/ownership.xml","form_type":"4"}},{"id":1171933,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":71334,"kind":"person","name":"Walker Karen Marie","position":1,"cik":"0002008556","reported_name":"Walker Karen Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-04-15T21:40:15.000Z","date":"2025-04-11","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award of common stock, 1/4th of which shall vest on April 11, 2026, and 1/4th of which shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":22636,"source":{"system":"sec-edgar","filing":"0000950170-25-054342","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008556/000095017025054342/ownership.xml","form_type":"4"}},{"id":1485262,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":71334,"kind":"person","name":"Walker Karen Marie","position":1,"cik":"0002008556","reported_name":"Walker Karen Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T22:56:07.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":9636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter."}],"balance_after":82648,"derivative":{"exercise_price":4.42,"underlying":"Common Stock","underlying_shares":9636},"source":{"system":"sec-edgar","filing":"0000950170-24-071493","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2008556/000095017024071493/ownership.xml","form_type":"4"}},{"id":1485261,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":71334,"kind":"person","name":"Walker Karen Marie","position":1,"cik":"0002008556","reported_name":"Walker Karen Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-06-10T22:56:07.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":9636,"price":4.42,"value":42591.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter."}],"balance_after":9636,"source":{"system":"sec-edgar","filing":"0000950170-24-071493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008556/000095017024071493/ownership.xml","form_type":"4"}}]}